Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Credit Suisse Maintains Outperform on Constellium, Lowers Price Target to $22

Credit Suisse analyst Curt Woodworth maintains Constellium (NYSE:CSTM) with a Outperform and lowers the price target from $24 to $22.
byBenzinga Newsdesk
December 1, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Credit Suisse analyst Curt Woodworth maintains Constellium (NYSE:CSTM) with a Outperform and lowers the price target from $24 to $22.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Scilex Holding Company Generates Record Monthly Revenue In October 2023 And Provides Certain Preliminary Unaudited Financial Results For Gross And Net Sales For The One Month Ended October 2023, And Year-To-Date Through October 31, 2023

By Benzinga Newsdesk
November 1, 9:23 AM
Scilex Holding Company (NASDAQ:SCLX, "Scilex" or "Company")))), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute

SCLX